These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38943996)
1. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary. Hwang J; Lee Y; Yoo SK; Kim JI Neoplasia; 2024 Sep; 55():101021. PubMed ID: 38943996 [TBL] [Abstract][Full Text] [Related]
2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710 [TBL] [Abstract][Full Text] [Related]
3. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel. Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771 [TBL] [Abstract][Full Text] [Related]
4. Predicting cancer origins with a DNA methylation-based deep neural network model. Zheng C; Xu R PLoS One; 2020; 15(5):e0226461. PubMed ID: 32384093 [TBL] [Abstract][Full Text] [Related]
5. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary. Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390 [TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles. Stark L; Kasajima A; Stögbauer F; Schmidl B; Rinecker J; Holzmann K; Färber S; Pfarr N; Steiger K; Wollenberg B; Ruland J; Winter C; Wirth M Clin Epigenetics; 2024 Mar; 16(1):47. PubMed ID: 38528631 [TBL] [Abstract][Full Text] [Related]
7. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation. Raghu A; Raghu A; Wise JF JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787 [TBL] [Abstract][Full Text] [Related]
8. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis. Ding W; Chen G; Shi T Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380 [TBL] [Abstract][Full Text] [Related]
10. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin. Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960 [TBL] [Abstract][Full Text] [Related]
11. Tracing unknown tumor origins with a biological-pathway-based transformer model. Xie J; Chen Y; Luo S; Yang W; Lin Y; Wang L; Ding X; Tong M; Yu R Cell Rep Methods; 2024 Jun; 4(6):100797. PubMed ID: 38889685 [TBL] [Abstract][Full Text] [Related]
12. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary. Chen K; Zhang F; Yu X; Huang Z; Gong L; Xu Y; Li H; Yu S; Fan Y J Transl Med; 2022 Apr; 20(1):158. PubMed ID: 35382836 [TBL] [Abstract][Full Text] [Related]
13. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data. Mallik S; Seth S; Bhadra T; Zhao Z Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782 [TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning. Liu B; Liu Y; Pan X; Li M; Yang S; Li SC Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31590287 [TBL] [Abstract][Full Text] [Related]
16. CpG methylation signature predicts prognosis in breast cancer. Du T; Liu B; Wang Z; Wan X; Wu Y Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283 [TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers. Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718 [No Abstract] [Full Text] [Related]
18. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. Kaur H; Bhalla S; Raghava GPS PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer. Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004 [TBL] [Abstract][Full Text] [Related]
20. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Yang X; Gao L; Zhang S Brief Bioinform; 2017 Sep; 18(5):761-773. PubMed ID: 27436122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]